Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2014

Feb 14, 2014

284_dirs_2014-02-14_be88ebb1-4caa-4381-acc3-835fd2398e67.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-02-14

Reporting Person: Golestani Clark (EVP & Chief Info Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-14 Common Stock M 6375.0000 $48.2400 Acquired 12036.1200 Direct
2014-02-14 Common Stock S 1190.0000 $55.4700 Disposed 10846.1200 Direct
2014-02-14 Common Stock S 4800.0000 $55.4723 Disposed 6046.1200 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-14 Stock Option (right to buy) $48.2400 M 6375.0000 Disposed 2014-02-26 Common Stock (6375.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock - 401(k) Plan 8156.8746 Indirect
Common Stock 2944.0000 Indirect

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Includes shares acquired and dividends earned through January 8, 2014, in the Merck U.S. Savings Plan, a 401(k) plan.